Humans cannot make cobalamin (vitamin B12) and take it from animal foods such as meat, fish, eggs, and milk. It reaches the two enzymes that need it through a chain of carriers: binding proteins in the gut, a receptor in the ileum, transcobalamin in the blood, a receptor on the cell surface, two exit proteins in the lysosome, and a processing protein in the cytosol. Then the chain splits. One branch makes adenosylcobalamin in the mitochondrion for methylmalonyl-CoA mutase, the last enzyme of the propionate pathway; the other makes methylcobalamin in the cytosol for methionine synthase, the remethylation step of methionine and homocysteine metabolism. This page is the bridge between those two. Where a defect sits decides which enzyme fails, and so whether methylmalonic acid, homocysteine, or both rise.
Where the cbl names come from. The letters are complementation groups, not steps. Fibroblasts from two patients were fused into a single cell; if the fused cell regained function, the two defects lay in different genes, and patients whose cells could not rescue each other formed one group. The first such experiment, with cells fused by Sendai virus, showed that cblA, cblB, and cblC were three separate groups (genetic complementation in heterokaryons of fibroblasts defective in cobalamin metabolism, 1975). The letters were then given largely in the order in which the groups were found (advances in the understanding of cobalamin assimilation and metabolism, 2010), long before the genes were known. That is why the letter says nothing about position: cblC acts upstream of cblA, and cblH turned out to be a variant of cblD.
- food → haptocorrin-bound cobalamin: in the stomach, pepsin releases cobalamin from food protein, and haptocorrin (TCN1), a binding protein from saliva, picks it up.
- haptocorrin-bound cobalamin → intrinsic factor-cobalamin: in the small intestine, pancreatic proteases digest haptocorrin and intrinsic factor (CBLIF, formerly GIF), secreted by the parietal cells of the stomach, takes the cobalamin. Lost in hereditary intrinsic factor deficiency.
- intrinsic factor-cobalamin → enterocyte: cubam, the receptor built from cubilin (CUBN) and amnionless (AMN), takes up the complex in the terminal ileum. Lost in Imerslund-Gräsbeck syndrome.
- blood → cell: transcobalamin (TCN2) carries only 10% to 25% of the cobalamin in plasma, but it is the carrier cells take up; haptocorrin carries the rest and does not deliver it to most tissues. The transcobalamin receptor (CD320) brings the complex into the cell by endocytosis. Blocked in transcobalamin deficiency.
- lysosome → cytosol: transcobalamin is digested in the lysosome, and free cobalamin leaves through LMBD1 (LMBRD1) and ABCD4 (ABCD4), which work as a complex. Lost in cblF (LMBRD1) and cblJ (ABCD4).
- cobalamin → processed cobalamin: the MMACHC protein (MMACHC) removes the upper ligand (cyano, hydroxo, methyl, or adenosyl), using glutathione. Processed cobalamin feeds both branches, which is why loss of this step starves both enzymes. Blocked in cobalamin C deficiency.
- The branch point: the MMADHC protein (MMADHC) binds the MMACHC protein and is thought to direct cobalamin to the mitochondrion or to methionine synthase. Its N-terminal region, with a mitochondrial targeting sequence, serves the mitochondrial branch; its C-terminal region serves methionine synthase. So cblD (MMADHC) has three biochemical variants, set by where the variant falls: truncating variants near the start of the gene remove only the mitochondrial branch (cblD variant 2, methylmalonic aciduria alone); missense variants near the end remove only the cytosolic branch (cblD variant 1, homocystinuria alone); and truncating variants in the middle and end remove both (cblD combined).
- cobalamin → adenosylcobalamin (mitochondrion): the adenosyltransferase, the MMAB protein (MMAB), transfers the 5'-deoxyadenosyl group of ATP to cobalamin and hands adenosylcobalamin to the mutase. Lost in cblB, which the methylmalonic acidemia page covers.
- adenosylcobalamin → active methylmalonyl-CoA mutase: the MMAA protein (MMAA), a GTPase, is needed to load adenosylcobalamin onto the mutase. Blocked in cobalamin A deficiency.
- methylmalonyl-CoA → succinyl-CoA: methylmalonyl-CoA mutase (MMUT), with adenosylcobalamin. Deficient in methylmalonic acidemia, a disorder of the propionate pathway that this pathway feeds.
- homocysteine + 5-methyltetrahydrofolate → methionine (cytosol): methionine synthase (MTR) takes the methyl group from 5-methyltetrahydrofolate onto its bound cobalamin, making methylcobalamin, and passes it to homocysteine. Every turn regenerates cob(I)alamin, which now and then oxidizes and leaves the enzyme inactive; methionine synthase reductase (MTRR) reactivates it by reductive methylation, with S-adenosylmethionine as the methyl donor. Blocked in cobalamin E and G deficiency: cblE at the reductase, cblG at the synthase.
- Regulators of MMACHC: MMACHC needs a transcription complex to be expressed. Loss of its X-linked coregulator HCFC1 (HCFC1) causes cblX, with less MMACHC protein, the biochemistry of cblC, and usually a more severe neurologic picture. Two transcription factors in the same complex, THAP11 and ZNF143, have each been reported in one person with a cblX-like disorder. Separately, a splice variant in PRDX1, the neighboring gene on the opposite strand, drives antisense transcription through MMACHC and methylates its promoter, silencing that allele; this is epi-cblC, covered on the cobalamin C deficiency page.
- Transcobalamin deficiency: cobalamin reaches the blood but not the cells, so both coenzymes run short. Megaloblastic anemia or pancytopenia, failure to thrive, vomiting and diarrhea, mouth ulcers, and immune deficiency begin in the first months. Methylmalonic acid and total homocysteine rise, yet serum B12 is usually normal. Early, frequent parenteral cobalamin gives a good early outcome; late or inadequate treatment has left lasting neurologic and visual damage.
- Cobalamin C deficiency: the most common inborn error of intracellular cobalamin metabolism. Unprocessed cobalamin cannot reach either branch, so methylmalonic acid and total homocysteine rise together and methionine is low or normal. Infantile disease brings maculopathy and progressive retinopathy.
- Cobalamin A deficiency (cblA): adenosylcobalamin is made but not loaded onto the mutase. Isolated methylmalonic acidemia that nearly always responds to hydroxocobalamin, with a milder course than mut0 or cblB.
- Methylmalonic acidemia (the mutase, cblB, and cblD variant 2): isolated methylmalonic acidemia with normal homocysteine. Complete deficiency of the mutase itself (mut0, MMUT) is the most common and severe form, and cblB usually behaves like it.
- Cobalamin E and G deficiency: methionine synthase cannot work, so total homocysteine is high, methionine is low, and methylmalonic acid is normal. Megaloblastic anemia with developmental delay, hypotonia, and seizures, usually in infancy.
- Also on this pathway, without a page here yet: hereditary intrinsic factor deficiency (CBLIF) and Imerslund-Gräsbeck syndrome (CUBN, AMN), both juvenile megaloblastic anemia from failed absorption, the second often with proteinuria because cubam also reclaims protein in the kidney; CD320 deficiency, found mostly through a raised C3 on newborn screening; most infants homozygous for the common p.Glu88del allele never have a raised C3, and none of nine followed had abnormal cobalamin metabolism after the newborn period (clinical relevance of CD320 p.E88del, a variant in the transcobalamin receptor gene, 2022); cblF (LMBRD1) and cblJ (ABCD4), the lysosomal exit defects; cblD (MMADHC) in its combined and homocystinuria-only forms; and cblX (HCFC1).
Three measurements place the block: methylmalonic acid (urine organic acids or plasma), plasma total homocysteine, and plasma methionine.
| Pattern | Where the block is | Disorders |
|---|---|---|
| Methylmalonic acid high, total homocysteine normal | Mitochondrial branch, or the mutase itself | cblA, cblB, cblD variant 2, MMUT deficiency |
| Total homocysteine high with methionine low or normal, methylmalonic acid normal | Cytosolic branch | cblE, cblG, cblD variant 1; MTHFR deficiency gives the same picture without megaloblastic anemia |
| Both high, methionine low or normal | Above the branch point | Transcobalamin deficiency, cblF, cblJ, cblC, cblD combined, cblX |
- Serum B12 does not exclude these disorders. It is usually normal in transcobalamin deficiency and in the intracellular disorders, because the vitamin reaches the blood normally; cblF and cblJ are the exceptions, reported with low serum B12 at diagnosis. It is low when absorption fails (intrinsic factor deficiency, Imerslund-Gräsbeck syndrome) and in dietary or maternal B12 deficiency.
- Low serum B12 without deficiency: haptocorrin carries most plasma cobalamin but delivers it only to the liver, so haptocorrin deficiency (TCN1) lowers serum B12 without any sign of cobalamin deficiency.
- Nutritional B12 deficiency mimics a combined defect. A breastfed infant of a vegan mother, or of a mother with subclinical pernicious anemia, can have high methylmalonic acid and homocysteine and a raised C3 on newborn screening. Measure B12 in both infant and mother.
- Methionine separates the remethylation defects (low or normal) from homocystinuria due to CBS deficiency (high), where homocysteine also rises.
- cblX does not always read as combined: methylmalonic acid is raised, but total homocysteine ranges from normal to high.
- Newborn screening flags the disorders with methylmalonic acid through C3 (propionylcarnitine). cblD variant 1, cblE, and cblG do not raise C3 and are often missed; programs that follow a low methionine with a second-tier total homocysteine have found cblE and cblG.
Both up, look up: when methylmalonic acid and homocysteine both rise, the block is above the branch point (transport, lysosomal exit, or the MMACHC protein). When only one rises, the block is on that branch: methylmalonic acid alone is the mitochondrial arm, homocysteine alone the cytosolic arm.